New mRNA flu vaccine approved in the U.S. awaits approval in Canada
Audio narration · Coming soon
A new mRNA vaccine for the flu, which is faster to produce and more precise than traditional flu shots, has been approved in the U.S. This vaccine is currently awaiting approval in Canada, potentially offering improved flu protection in the near future.
Why this matters
PRISM scored this story 60/100 for interest.
Originally published by gnews